Payment overview · 2025
General Payments
$18.97
1 reported records · 1 companies
Healthcare provider profile · identity verified
Lawrence D Mass, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LOWER GWYNEDD, PA · NPI 1316943830
Verified facts
What the public records show
CMS Open Payments records show Lawrence D Mass, MD received $18.97 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.97 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.97 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $18.97 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $18.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 612 | 180 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 542 | 153 |
| Amlodipine Besylate | Amlodipine Besylate | 350 | 104 |
| Lisinopril | Lisinopril | 348 | 96 |
| Levothyroxine Sodium | Levothyroxine Sodium | 270 | 67 |
| Losartan Potassium | Losartan Potassium | 247 | 76 |
| Pantoprazole Sodium | Pantoprazole Sodium | 231 | 71 |
| Metformin Hcl | Metformin Hcl | 212 | 65 |
| Pravastatin Sodium | Pravastatin Sodium | 177 | 49 |
| Omeprazole | Omeprazole | 164 | 59 |
| Simvastatin | Simvastatin | 153 | 48 |
| Finasteride | Finasteride | 140 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 138 | 36 |
| Famotidine | Famotidine | 129 | 35 |
| Allopurinol | Allopurinol | 126 | 32 |
| Zolpidem Tartrate | Zolpidem Tartrate | 124 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 123 | 39 |
| Alendronate Sodium | Alendronate Sodium | 116 | 33 |
| Gabapentin | Gabapentin | 115 | 33 |
| Fluticasone Propionate | Fluticasone Propionate | 108 | 41 |
| Tamsulosin Hcl | Tamsulosin Hcl | 106 | 38 |
| Eliquis | Apixaban | 104 | 25 |
| Sertraline Hcl | Sertraline Hcl | 99 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 89 | 31 |
| Januvia | Sitagliptin Phosphate | 83 | 17 |
| Synthroid | Levothyroxine Sodium | 83 | 22 |
| Jardiance | Empagliflozin | 82 | 24 |
| Chlorthalidone | Chlorthalidone | 75 | 22 |
| Furosemide | Furosemide | 73 | 24 |
| Ezetimibe | Ezetimibe | 67 | 19 |
| Montelukast Sodium | Montelukast Sodium | 67 | 17 |
| Lorazepam | Lorazepam | 61 | 22 |
| Bupropion Xl | Bupropion Hcl | 60 | 15 |
| Carvedilol | Carvedilol | 59 | 19 |
| Prednisone | Prednisone | 58 | 32 |
| Clonazepam | Clonazepam | 53 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 16 |
| Alprazolam | Alprazolam | 52 | 14 |
| Trazodone Hcl | Trazodone Hcl | 52 | 15 |
| Clopidogrel | Clopidogrel Bisulfate | 50 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 49 | 16 |
| Meloxicam | Meloxicam | 48 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 44 | suppressed |
| Trulicity | Dulaglutide | 44 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 42 | 12 |
| Xarelto | Rivaroxaban | 42 | suppressed |
| Glimepiride | Glimepiride | 41 | 12 |
| Valsartan | Valsartan | 41 | 15 |
| Atenolol | Atenolol | 40 | 14 |
| Benazepril Hcl | Benazepril Hcl | 40 | suppressed |
| Mirtazapine | Mirtazapine | 40 | 17 |
| Valacyclovir | Valacyclovir Hcl | 37 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | 12 |
| Spironolactone | Spironolactone | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 34 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | 12 |
| Nifedipine Er | Nifedipine | 32 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 31 | 17 |
| Ozempic | Semaglutide | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Repatha Sureclick | Evolocumab | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 24 |
| Warfarin Sodium | Warfarin Sodium | 27 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 26 | suppressed |
| Ketoconazole | Ketoconazole | 25 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 19 |
| Pregabalin | Pregabalin | 25 | suppressed |
| Diazepam | Diazepam | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 22 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Potassium Chloride | Potassium Chloride | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 18 |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Loperamide | Loperamide Hcl | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Testosterone | Testosterone | 20 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 19 | 13 |
| Paxlovid | Nirmatrelvir/Ritonavir | 19 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 18 | suppressed |
| Celecoxib | Celecoxib | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 17 | suppressed |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 12 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Verapamil Er | Verapamil Hcl | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Lovastatin | Lovastatin | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Victoza 3-Pak | Liraglutide | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.97 · 1 records | Amgen Inc. | OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error